Summary
- Current Price
- As of today, BNTX price is $93.15, down -0.56% in the most recent trading session on
- Current Price All-Time High
- BNTX price is currently -79.92% below its historical high of $464.00 set on
- Market Cap
- BNTX current market cap is $23B, down -12.83% year-over-year
- Revenue
- BNTX current annual revenue is $3.24B, up +8.84% year-over-year
- Next Earnings
- The next earnings release for BNTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | BioNTech SE |
| Ticker | NASDAQ: BNTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Germany |
| IPO | |
| Indexes | Not included |
| Website | biontech.de |
| Employees | 6,772 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $93.15 | |
| Price, 1D Change | -0.56% | |
| Market Cap | $23B | |
| TTM Dividend Yield | - | |
| PE Ratio | - | |
| Beta | 0.86 | |
| Revenue | $3.24B | |
| Revenue, 1Y Change | +8.84% | |
| EPS | -$5.30 | |
| EPS, 1Y Change | -77.21% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $2.13 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$5.30 | |
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| Revenue | $3.24B | |
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $93.15 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $4.14 | - | |
| - | -$2.99 | - | |
| - | -$5.30 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $4.13B | - | |
| - | $2.98B | - | |
| - | $3.24B | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -16.58% | |
| Price, 3Y | -11.67% | |
| Market Cap, 1Y | -12.83% | |
| Market Cap, 3Y | -7.46% | |
| Revenue, 1Y | +8.84% | |
| Revenue, 3Y | -82.20% | |
| EPS, 1Y | -77.21% | |
| EPS, 3Y | -113.36% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $93.15 | |
| SMA 200 | $97.89 | |
| SMA 50 | $91.38 | |
| EMA 200 | $96.82 | |
| EMA 50 | $92.28 | |
| MACD | $0.09 | |
| Beta | 0.86 | |
| ATR | $2.78 | |
| 14-Day RSI | 55.39 | |
| 10-Day Volatility | 25.76% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $2.13 | |
| Upcoming | N/A | N/A |
| Dividend Yield | - | |
| Total Dividend | - | |
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $3.24B | |
| EPS | -$5.30 | |
| Gross Profit | $2.51B | |
| Gross Margin | 77.64% | |
| Operating Income | -$733.01M | |
| Operating Margin | -22.63% | |
| Net Income | -$1.28B | |
| Net Margin | -39.59% | |
| EBITDA | -$300.99M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.01 | |
| 7.54 | ||
| 7.49 | ||
| - | ||
| 2 | ||
| 6.26 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| 7.57 | ||
| 1.15 | ||
| -33.82 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $22.58B | |
| $17.43B | ||
| $25.82B | ||
| $18.96B | ||
| $3.25B | ||
| $2.52B | ||
| Total Debt | $314.05M | |
| $61.31M | ||
| $628.21M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $4.52B | ||
| $3.25B | ||
| $724.32M | ||
| $704.68M | ||
| $432.02M | ||
| $0.00 | ||
| $96.27M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $514.63M | ||
| -$2.79B | ||
| -$59.70M | ||
| Capex | $845.30M | |
| -$330.67M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Evercore ISI Group | → | |
| Citigroup | → | |
| Morgan Stanley | → | |
| UBS | → | |
| Bernstein | ||
| Wells Fargo | → | |
| Canaccord Genuity | → | |
| HC Wainwright & Co. | → | |
| Morgan Stanley | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with BNTX
FAQ
- What is the ticker symbol for BioNTech SE?
- The ticker symbol for BioNTech SE is NASDAQ:BNTX
- Does BioNTech SE pay dividends?
- No, BioNTech SE does not pay dividends
- What sector is BioNTech SE in?
- BioNTech SE is in the Healthcare sector
- What industry is BioNTech SE in?
- BioNTech SE is in the Biotechnology industry
- What country is BioNTech SE based in?
- BioNTech SE is headquartered in Germany
- When did BioNTech SE go public?
- BioNTech SE initial public offering (IPO) was on October 10, 2019
- Is BioNTech SE in the S&P 500?
- No, BioNTech SE is not included in the S&P 500 index
- Is BioNTech SE in the NASDAQ 100?
- No, BioNTech SE is not included in the NASDAQ 100 index
- Is BioNTech SE in the Dow Jones?
- No, BioNTech SE is not included in the Dow Jones index
- When was BioNTech SE last earnings report?
- BioNTech SE's most recent earnings report was on August 4, 2026
- When does BioNTech SE report earnings?
- The next expected earnings date for BioNTech SE is November 3, 2026
Data Sources & References
- BNTX Official Website www.biontech.de
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1776985/000177698526000017/0001776985-26-000017-index.htm
- BNTX Profile on Yahoo Finance finance.yahoo.com/quote/BNTX
- BNTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bntx
